RS20060125A - A method of removing the triphenylmethane protecting group - Google Patents

A method of removing the triphenylmethane protecting group

Info

Publication number
RS20060125A
RS20060125A YUP-2006/0125A YUP20060125A RS20060125A RS 20060125 A RS20060125 A RS 20060125A YU P20060125 A YUP20060125 A YU P20060125A RS 20060125 A RS20060125 A RS 20060125A
Authority
RS
Serbia
Prior art keywords
protecting group
triphenylmethane protecting
triphenylmethane
ring
tetrazoles
Prior art date
Application number
YUP-2006/0125A
Other languages
English (en)
Inventor
Stanislav Radl
Jan Stach
Ondrej Klecan
Original Assignee
Zentiva A.S.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20032319A external-priority patent/CZ297016B6/cs
Priority claimed from CZ20040733A external-priority patent/CZ298329B6/cs
Application filed by Zentiva A.S., filed Critical Zentiva A.S.,
Publication of RS20060125A publication Critical patent/RS20060125A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Ova prijave se odnosi na postupak za uklanjanje grupe za zaštitu trifenilmetana iz iz l-trifenilmetil-5-( 4' -supst. aminometil-l, l' -bifenil-2-il)-1H-tetrazola opšte formule I u kojoj R predstavlja grupe sa formulama i gde R1, R2, i R3 mogu da budu H, halogen, nerazgranati ili razgranati C1-C5alkil, C1-C5hidroksialkil, C1-C5alkoksi, C1-C5 alkoksimetil, ili benzil, ili gde R2 i R3 mogu zajedno da grade C5-C7 zasićeni ili nezasićeni prsten, po slobodnom izboru nesupstituisan ili supstituisan aromatični prsten, i gde se postupak vrši solvolizom u prostom anhidrovanom alkoholu sa Cl do C5 atoma ugljenika u neutralnoj ili blago baznoj sredini. Postupak je pogodan za dobijanje lekova, kao što su kalijumove soli lozartana, irbezartana ili valzartana ili kandezartan cileksetila.
YUP-2006/0125A 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group RS20060125A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20032319A CZ297016B6 (cs) 2003-08-27 2003-08-27 Zpusob odstranování trifenylmethanové chránicí skupiny z 1-trityl-5-(4'-subst. aminomethyl-1,1' -bifenyl-2-yl)-1H-tetrazolu a zpusob výroby draselné soli losartanu, irbesartanu a valsartanu s jeho pouzitím
CZ20040733A CZ298329B6 (cs) 2004-06-16 2004-06-16 Zpusob výroby 1-(cyklohexyloxykarbonyloxy)ethyl-2-ethoxy-1-[[2´-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl]benzimidazol-7-karboxylátu (candesartan cilexetilu)
PCT/CZ2004/000051 WO2005021535A2 (en) 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group

Publications (1)

Publication Number Publication Date
RS20060125A true RS20060125A (en) 2008-06-05

Family

ID=34276338

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2006/0125A RS20060125A (en) 2003-08-27 2004-08-26 A method of removing the triphenylmethane protecting group

Country Status (13)

Country Link
US (1) US20060287537A1 (sr)
EP (1) EP1658281B1 (sr)
AT (1) ATE482950T1 (sr)
CA (1) CA2536781A1 (sr)
DE (1) DE602004029373D1 (sr)
EA (1) EA011507B1 (sr)
ES (1) ES2348300T3 (sr)
HR (1) HRP20060119A2 (sr)
PL (2) PL1658281T3 (sr)
PT (1) PT1658281E (sr)
RS (1) RS20060125A (sr)
SK (1) SK50142006A3 (sr)
WO (1) WO2005021535A2 (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2555294A1 (en) 2004-02-11 2005-08-25 Marina Yu Etinger Candesartan cilexetil polymorphs
WO2006050922A1 (en) * 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan
SI22127A (sl) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ299902B6 (cs) * 2005-10-27 2008-12-29 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
EP2260018A2 (en) 2008-04-07 2010-12-15 Hetero Research Foundation Process for preparation of valsartan intermediate
WO2010046804A2 (en) * 2008-10-21 2010-04-29 Alembic Limited A process for preparation of losartan potassium form i
EP2432777A1 (en) 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Process for the preparation of olmesartan medoxomil
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN103012382B (zh) * 2012-12-05 2016-10-05 迪沙药业集团有限公司 一种奥美沙坦酯的制备方法
CN107001806B (zh) * 2014-09-29 2020-12-04 斯克利普斯研究院 用于治疗心肺疾病的鞘氨醇-1-磷酸盐受体调节剂
US11327065B1 (en) * 2021-08-27 2022-05-10 Jubilant Generics Limited Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30484A (en) * 1990-02-19 1997-05-28 Ciba Geigy Acy compounds pharmaceutical composition containing said compound and method of use thereof
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
AT395853B (de) * 1991-01-31 1993-03-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5281604A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
SK722003A3 (en) * 2001-05-18 2003-12-02 Aurobindo Pharma Ltd Process for the crystallization of losartan potassium

Also Published As

Publication number Publication date
EA011507B1 (ru) 2009-04-28
PL379886A1 (pl) 2006-11-27
HRP20060119A2 (en) 2006-05-31
WO2005021535A3 (en) 2005-06-09
WO2005021535A2 (en) 2005-03-10
US20060287537A1 (en) 2006-12-21
DE602004029373D1 (de) 2010-11-11
ES2348300T3 (es) 2010-12-02
ATE482950T1 (de) 2010-10-15
EP1658281B1 (en) 2010-09-29
PL1658281T3 (pl) 2010-12-31
EA200600079A1 (ru) 2006-08-25
EP1658281A2 (en) 2006-05-24
SK50142006A3 (sk) 2006-05-04
PT1658281E (pt) 2010-10-12
CA2536781A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
RS20060125A (en) A method of removing the triphenylmethane protecting group
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
WO2008105442A1 (ja) スルホンアミド誘導体
NO20074071L (no) Hydrazinometyl, hydrozonometyl og 5-leddete heterocykliske forbindelser som virker som MTOR inhibitorer og anvendelse derav som anti-cancer midler
RS53348B (sr) Postupak za pripremu 3-supstituisanih 2-amino-5-halobenzamida
WO2008111441A1 (ja) 医薬組成物
RS54047B1 (sr) Postupak za dobijanje jedinjenja 4-oksohinolina
WO2005095395A3 (en) Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
RS51161B (sr) 5-supstituisani hinolin- ili izohinolin-derivati,postupak za njihovo dobijanje i njihova primena u suzbijanju zapaljenja
NO20085269L (no) 2-tioksantinderivater som fungerer som MPO-inhibitorer
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
SV2010003483A (es) Pirimidinas biciclicas fusionadas
AR069436A1 (es) Compuestos de piridina
WO2007146124A3 (en) Deuterated tadalafil derivatives
AR073498A1 (es) Derivados de tieno [2-3-d] pirimidin
WO2008136444A1 (ja) 縮合複素環誘導体
WO2008105058A1 (ja) スルホンアミド化合物
WO2007147771A3 (en) Tetralin and indane derivatives and uses thereof
EA201170595A1 (ru) ПРОИЗВОДНОЕ ФЕНАНТРОИНДОЛИЗИДИНА И ИНГИБИТОР NFkB, СОДЕРЖАЩИЙ ЕГО В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА
MX2010001566A (es) Derivado de aminopirazolamida.
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
UA100376C2 (en) Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
ATE445619T1 (de) Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren
MX2009004558A (es) Compuesto amida o su sal, e inhibidor de formacion de biopelicula, quitador de biopelicula y bactericida usando cada uno el compuesto amida o su sal.